Search Results

Return to List
Results 1–11 of 11
Title Date
1.

The Apgar Score

Number 333

(Reaffirmed 2010, Replaces No. 174, July 1996)

ABSTRACT The Apgar score provides a convenient shorthand for reporting the status of the newborn infant and the response to resuscitation The Apgar score has been used inappropriately to predict specific neurologic outcome in the term infant There are no consistent data on the significance of the ...

May 2006

PDF Format
2.

Amnioinfusion Does Not Prevent Meconium Aspiration Syndrome

Number 346

(Reaffirmed 2014)

ABSTRACT Amnioinfusion has been advocated as a technique to reduce the incidence of meconium aspiration and to improve neonatal outcome However a large proportion of women with meconiumstained amniotic fluid have infants who have taken in meconium within the trachea or bronchioles before meconium ...

October 2006

PDF Format
3.

Management of Delivery of a Newborn With Meconium-Stained Amniotic Fluid

Number 379

(Reaffirmed 2013)

ABSTRACT In accordance with the new guidelines from the American Academy of Pediatrics and the American Heart Association all infants with meconiumstained amniotic fluid should no longer routinely receive intrapartum suctioning If meconium is present and the newborn is depressed the clinician shou...

September 2007

PDF Format
4.

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Number 455

Reaffirmed 2015

Abstract Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format
5.

Planned Home Birth

Number 476

Reaffirmed 2015

ABSTRACT Although the Committee on Obstetric Practice believes that hospitals and birthing centers are the safest setting for birth it respects the right of a woman to make a medically informed decision about delivery Women inquiring about planned home birth should be informed of its risks and ben...

February 2011

PDF Format
6.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Number 485

(Replaces No. 279, December 2002, Reaffirmed 2015)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format
7.

Placenta Accreta

Number 529

Reaffirmed 2014

ABSTRACT Placenta accreta is a potentially lifethreatening obstetric condition that requires a multidisciplinary approach to management The incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate Women at greatest risk of placenta accreta are those w...

July 2012

PDF Format
8.

Medically Indicated Late-Preterm and Early-Term Deliveries

Number 560

ABSTRACT The neonatal risks of late preterm 34 0736 67 weeks of gestation and earlyterm 37 0738 67 weeks of gestation births are well established However there are a number of maternal fetal and placental complications in which either a latepreterm or earlyterm delivery is warranted The timing of ...

April 2013

PDF Format
9.

Nonmedically Indicated Early-Term Deliveries

Number 561

ABSTRACT For certain medical conditions available data and expert opinion support optimal timing of delivery in the latepreterm or earlyterm period for improved neonatal and infant outcomes However for nonmedically indicated earlyterm deliveries such an improvement has not been demonstrated Morbid...

April 2013

PDF Format
10.

Magnesium Sulfate Use in Obstetrics

Number 573

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

September 2013

PDF Format
11.

Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period

Number 623

(Replaces Committee Opinion Number 514, December 2011)

ABSTRACT Acuteonset severe systolic hypertension severe diastolic hypertension or both can occur in pregnant women or women in the postpartum period Introducing standardized evidencebased clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to re...

February 2015

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998